Skip to content
LexBuild

Manufacturer of Controlled Substances; Notice of Registration

---
identifier: "/us/fr/05-4232"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Manufacturer of Controlled Substances; Notice of Registration"
title_number: 0
title_name: "Federal Register"
section_number: "05-4232"
section_name: "Manufacturer of Controlled Substances; Notice of Registration"
positive_law: false
currency: "2005-03-04"
last_updated: "2005-03-04"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Justice Department"
document_number: "05-4232"
document_type: "notice"
publication_date: "2005-03-04"
agencies:
  - "Justice Department"
  - "Drug Enforcement Administration"
fr_citation: "70 FR 10681"
fr_volume: 70
---

#  Manufacturer of Controlled Substances; Notice of Registration

By notice dated October 18, 2004, and published in the *Federal Register* on October 25, 2004, (69 FR 62295), National Center for Natural Products Research— NIDA MProject, University of Mississippi, 135 Coy Waller Lab Complex, University, Mississippi 38677, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedule I:

| Drug | Schedule |
| --- | --- |
| Marihuana (7360) | I |
| Tetrahydrocannabinols (7370) | I |

The company plans to cultivate marihuana for the National Institute of Drug Abuse for research approved by the Department of Health and Human Services.

No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of National Center for Natural Products Research—NIDA MProject, University of Mississippi to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated National Center for Natural Products Research—NIDA MProject, University of Mississippi to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.

Dated: February 22, 2005.

William J. Walker,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.